{"id":"W4389229579","doi":"10.1182/blood-2023-178698","title":"A Matching-Adjusted Indirect Comparison of Acalabrutinib with and without Obinutuzumab Versus Zanubrutinib in Treatment-Naïve Chronic Lymphocytic Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Chronic lymphocytic leukemia; Medicine; Internal medicine; Obinutuzumab; Oncology; Randomized controlled trial; Proportional hazards model; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003133191,0.0003996799,0.001166622,0.0005362109,0.00008580479,0.00003037838,0.0001903212,0.0002452525,0.00005463922],"category_scores_gemma":[0.0001270857,0.0003131774,0.00009909427,0.001352471,0.000325247,0.00009474854,0.0001496821,0.0003055777,0.0000879765],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.05216724,"about_ca_system_score_gemma":0.03398274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006240926,"about_ca_topic_score_gemma":0.002317959,"domain_scores_codex":[0.9970805,0.0001152213,0.0006064981,0.0006567605,0.0006925985,0.0008484331],"domain_scores_gemma":[0.9983277,0.0004521664,0.0002000077,0.0006490681,0.0000898131,0.000281242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.09722139,0.006778455,0.5808604,0.01430776,0.01573967,0.01046792,0.0865069,0.01736796,0.0591358,0.001531935,0.001828104,0.1082537],"study_design_scores_gemma":[0.7355831,0.01367737,0.06362923,0.002510454,0.002147308,0.001263714,0.004860284,0.09463472,0.07977201,0.00008153436,0.000733287,0.001106976],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954695,0.001123773,0.000003205698,0.00003257109,0.00008924919,0.001081601,0.00002015995,0.0002379652,0.001941976],"genre_scores_gemma":[0.998204,0.000338289,0.0002511934,0.00001326571,0.0001185051,0.0001214546,0.00009317933,0.00008365692,0.0007764438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6383617,"threshold_uncertainty_score":0.9999321,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05379710770167689,"score_gpt":0.3422837733442586,"score_spread":0.2884866656425817,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}